Worcester, MA, United States of America

Cara Weismann

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: University of Massachusetts. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cara Weismann. Retrieved from https://idiyas.com/inventor/cara-weismann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Cara Weismann

Introduction

Cara Weismann is an accomplished inventor based in Worcester, MA (US). She has made significant contributions to the field of genetic research, particularly in the modulation of adeno-associated virus (AAV) vector transgene expression. Her work is crucial for advancing treatments for various genetic disorders.

Latest Patents

Cara Weismann holds 1 patent for her invention titled "Modulation of AAV vector transgene expression." This patent focuses on recombinant adeno-associated viruses (rAAVs) that include artificial genetic regulatory elements to modulate transgene expression. The invention has implications for the treatment of lysosomal storage disorders, showcasing her innovative approach to genetic therapy.

Career Highlights

Weismann is affiliated with the University of Massachusetts, where she continues her research and development in genetic engineering. Her work has garnered attention for its potential to improve therapeutic strategies for genetic diseases.

Collaborations

Cara collaborates with notable colleagues, including Miguel Sena Esteves and Diane Golebiowski, who contribute to her research endeavors and enhance the impact of her work.

Conclusion

Cara Weismann's innovative contributions to genetic research and her patent on AAV vector transgene expression highlight her role as a leading inventor in her field. Her work promises to advance the treatment of genetic disorders and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…